The New York Mets are entering the final stretch of spring preparation with cautious optimism surrounding Francisco Lindor’s status for Opening Day. According to president of baseball operations David Stearns and manager Carlos Mendoza, the organization believes its star shortstop has a realistic chance to be ready when the regular season begins. Still, the timeline leaves very little margin for error, and the club is carefully evaluating its depth options in case Lindor’s recovery extends beyond expectations.
Lindor recently underwent surgery to address an issue that is expected to sideline him for approximately six weeks. That projection places his return right on the doorstep of Opening Day. While the Mets have publicly expressed confidence in the rehab process, the nature of the timeline means any minor setback could push his availability into early April. For a team with postseason aspirations, ensuring stability at shortstop is a priority.

The Mets are well aware of how integral Lindor is to their success. Beyond his Gold Glove-caliber defense and switch-hitting power, Lindor serves as a central clubhouse presence and lineup anchor. When healthy, he provides durability, leadership, and consistency at one of the most demanding positions on the field. Losing him, even briefly, would test the organization’s infield depth and early-season chemistry.
In response, the Mets have begun distributing shortstop reps across several internal candidates during camp. Vidal Bruján, Ronny Mauricio, Jackson Cluff, Grae Kessinger, and Christian Arroyo are all expected to see time at the position as the coaching staff evaluates defensive reliability and offensive upside. Each player brings a slightly different profile. Bruján offers athleticism and speed, Mauricio carries intriguing offensive potential, and Arroyo has experience across multiple infield spots. However, none provides the proven production or defensive certainty Lindor offers.

Adding another layer to the situation is Bo Bichette’s presence on the roster. Although Bichette has extensive experience at shortstop earlier in his career, the Mets are not planning to shift him there. The organization is focused on his transition to third base and wants him concentrating on mastering that position rather than serving as an emergency solution at short. That strategic decision narrows the immediate pool of reliable shortstop options.
Given the uncertainty, discussion has turned to veteran infielder Jose Iglesias as a possible insurance option. Iglesias, 36, remains a free agent and is familiar with both the Mets organization and its clubhouse culture. He was a key contributor during the team’s 2024 campaign, a season in which the Mets advanced to the National League Championship Series. Iglesias became known not only for his defensive steadiness but also for the energy and chemistry he helped foster within the roster.

In 2024, Iglesias delivered one of the most productive seasons of his career. Over 85 games, he posted a .337 batting average with a .381 on-base percentage and a .448 slugging percentage, finishing with an .830 OPS. He contributed four home runs and 26 RBI while producing strong defensive metrics and a 3.1 WAR. His contact-oriented approach and ability to deliver timely hits made him a valuable piece of the lineup, particularly when injuries struck.
Equally important was his versatility. Iglesias has logged extensive innings at shortstop, second base, and third base throughout his career. That flexibility would allow the Mets to maintain lineup balance while waiting for Lindor to return to full strength. On a minor league deal, Iglesias would represent a low-risk, high-experience option capable of stepping into a starting role if needed.

However, the Mets must weigh recent performance trends as well. Iglesias’ production following his standout 2024 season dipped considerably, raising questions about sustainability at this stage of his career. While his glove remains dependable, teams often hesitate to commit guaranteed roster spots to aging infielders without clear offensive upside. For the Mets, the decision would likely come down to whether veteran stability outweighs the potential development time for younger players already in camp.
From a roster-building perspective, signing Iglesias to a minor league contract would offer flexibility without long-term obligation. He could compete during spring training and either break camp with the team or serve as immediate Triple-A depth. If Lindor proves fully ready by Opening Day, the Mets would not be forced into a difficult roster crunch. If Lindor requires additional recovery time, Iglesias could provide a familiar and steady presence.

The situation also underscores the broader importance of early-season depth for contending teams. Even short-term injuries can alter divisional races in April and May. The Mets, competing in a highly competitive National League East, cannot afford a prolonged slump caused by instability at a premium defensive position. Ensuring adequate coverage for Lindor is less about panic and more about prudent planning.
Manager Carlos Mendoza has emphasized that the organization will not rush Lindor back solely to meet an arbitrary date. While optimism remains, player health takes precedence. If Lindor demonstrates full mobility, strength, and timing in his rehab progression, he could very well take the field on Opening Day. If not, the Mets appear prepared to adjust accordingly.

As camp progresses, much will depend on how Lindor responds to increased baseball activities and how the infield depth options perform in exhibition games. Strong defensive showings or unexpected offensive surges from younger players could influence the front office’s approach. Conversely, if uncertainty lingers, a reunion with Iglesias may become increasingly appealing.
For now, the Mets are balancing confidence with caution. They believe in Lindor’s work ethic and recovery plan, but they also understand the unpredictability of rehabilitation timelines. With Opening Day approaching, every practice session and medical update will carry heightened significance.

